Virus-like particle vaccinology, from bench to bedside
MO Mohsen, MF Bachmann - Cellular & molecular immunology, 2022 - nature.com
Virus-like particles (VLPs) have become key tools in biology, medicine and even
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …
Inducing immune tolerance with dendritic cell-targeting nanomedicines
A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - nature.com
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …
that have shown promise in laboratory models of disease and early clinical trials. In contrast …
[HTML][HTML] Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
Vaccines generate high-affinity antibodies by recruiting antigen-specific B cells to germinal
centers (GCs), but the mechanisms governing the recruitment to GCs on secondary …
centers (GCs), but the mechanisms governing the recruitment to GCs on secondary …
Role of nanoscale antigen organization on B-cell activation probed using DNA origami
Vaccine efficacy can be increased by arraying immunogens in multivalent form on virus-like
nanoparticles to enhance B-cell activation. However, the effects of antigen copy number …
nanoparticles to enhance B-cell activation. However, the effects of antigen copy number …
[HTML][HTML] Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo
How antigen valency affects B cells in vivo during immune responses is not well understood.
Here, using HIV immunogens with defined valencies ranging from 1 to 60, we investigated …
Here, using HIV immunogens with defined valencies ranging from 1 to 60, we investigated …
Major findings and recent advances in virus–like particle (VLP)-based vaccines
MO Mohsen, L Zha, G Cabral-Miranda… - Seminars in …, 2017 - Elsevier
Virus-like particles (VLPs) have made giant strides in the field of vaccinology over the last
three decades. VLPs constitute versatile tools in vaccine development due to their …
three decades. VLPs constitute versatile tools in vaccine development due to their …
Clinical delivery of circular RNA: lessons learned from RNA drug development
Circular RNAs (circRNA) represent a distinct class of covalently closed-loop RNA molecules,
which play diverse roles in regulating biological processes and disease states. The …
which play diverse roles in regulating biological processes and disease states. The …
Synthetic nanoparticles for vaccines and immunotherapy
The immune system plays a critical role in our health. No other component of human
physiology plays a decisive role in as diverse an array of maladies, from deadly diseases …
physiology plays a decisive role in as diverse an array of maladies, from deadly diseases …
Immunogenicity of therapeutic protein aggregates
Therapeutic proteins have a propensity for aggregation during manufacturing, shipping, and
storage. The presence of aggregates in protein drug products can induce adverse immune …
storage. The presence of aggregates in protein drug products can induce adverse immune …
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher… - Nature …, 2019 - nature.com
The present vaccine against influenza virus has the inevitable risk of antigenic discordance
between the vaccine and the circulating strains, which diminishes vaccine efficacy. This …
between the vaccine and the circulating strains, which diminishes vaccine efficacy. This …